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Objective:  To evaluate the relationship between birth weight and the risk of pediatric Hodgkin 
lymphoma (HL, age at diagnosis: 0-19 years). 
Method:  We linked California statewide birth records from 1978-2009 and cancer diagnosis 
data from 1988-2011 to conduct a population-based case-control study with 1,216 cases and 
4,485 controls (matched on birth month and year, sex, and race/ethnicity).  Conditional logistic 
regression was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI) of 
pediatric HL overall and by age of diagnosis, controlling for other perinatal factors. 
Results: Compared to children with a normal birth weight (2500-3999 g), those who had a high 
birth weight (≥ 4000 g) had a significantly increased risk of pediatric HL overall (OR=1.23, 95% 
CI: 1.02-1.48). The magnitude of association was larger for subgroups of children whose age of 
diagnosis was 0-10 years (OR=1.56, 95% CI: 1.04-2.24) or 15-19 years (OR=1.43, 95% CI: 
1.11-1.83), while no association was observed in 11-14 year olds.  Compared to firstborn 
children, those who were third or higher in birth order had a significantly reduced risk of 
pediatric HL overall (OR=0.80, 95% CI: 0.67-0.95), and this association also varied by age of 
diagnosis.   
Conclusions:  In this study with the largest number of pediatric HL cases, high birth weight was 
associated with an increased disease risk.  The different findings by age of diagnosis regarding 
both birth weight and birth order underscore the importance to stratify pediatric HL by age at 
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In the United States (US), Hodgkin lymphoma (HL) is the third most common pediatric 
malignancy, accounting for approximately 4% of cancer diagnosed in children 0-14 years of 
age.
1
  The incidence of HL is higher in adolescents (3.0 cases per 100,000 person-years among 
ages 15-19 years in contrast to 0.6 cases per 100,000 person-years in children aged 0-14 years), 
among whom HL is the most commonly diagnosed malignancy and represents about 15% of 
cancer diagnoses in this age group.
1,2
  In 2014, there were a total of 1,140 estimated new cases of 
pediatric HL (age 0-19 years) in the US.
1
   Although survival rates are now extremely high due 
to improved treatments, pediatric HL survivors retain elevated risks of treatment-related 
morbidities over the long term, which can severely impact quality of life.
3
  The etiology of 
pediatric HL is not well understood, and research in this area remains a high priority. 
Recent epidemiologic investigations have evaluated various perinatal characteristics for 
possible associations with pediatric HL.  In particular, birth weight has been assessed in several 
of these studies as a potential marker for intrauterine growth, with inconsistent results.  Multiple 
studies
4-11
 and a meta-analysis published in 2012
12
  found no association between birth weight 
and risk of pediatric HL.  However, a large birth cohort study from Sweden observed a 
significant positive association between high birth weight and risk of HL in cases diagnosed 
under the age of 15 years, as well as those diagnosed at the age of 15-37 years.
13
 
Two factors could have contributed to the inconsistent findings.  First, given the rarity of 
pediatric HL, most existing studies included a relatively small number of cases and likely had 
suboptimal statistical power.  The number of HL cases in the studies included in the meta-
analysis
12
 ranged from 84 to 474, while the Swedish birth cohort study included 943 HL cases.  
2 
 
Second, different studies included HL cases who were diagnosed at different ages, with many 
focusing on HL cases diagnosed at the age of 0-14 years.
4-6,8,10,11
  
Given the high incidence of HL at the age of 15-19 years
1
 and the lack of consensus on 
the relation of birth weight to the risk of HL, we designed a population-based record linkage to 
conduct a large case-control study with an unprecedented sample size in order to clarify the role 
of birth weight in the etiology of pediatric HL, with a particular emphasis on covering the entire 




We linked California statewide birth records from 1978-2009 (maintained by the Vital 
Statistics Division of the California Department of Public Health) and cancer diagnosis records 
from 1988-2011 (collected by the California Cancer Registry).  Histologically confirmed cases 
of pediatric HL (aged 0-19 years at the time of diagnoses) were identified using information 
reported to the California Cancer Registry.  For each case, up to four controls were randomly 
sampled from statewide birth records and individually matched to each case on birth month and 
year, sex, and race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, Asian/Pacific 
Islander, and other).  Record linkage and the selection of cases and controls were performed by 
research staff at the California Cancer Registry.  The study protocol was approved by the 
Institutional Review Boards of California Health and Human Services and all participating 
academic institutions (Yale University, University of California, Berkeley, and University of 





The initial study population consisted of 1,323 pediatric HL cases and 5,292 matched 
controls.  In order to preserve data quality, we excluded individuals with missing or unknown 
values for at least one of the following variables: birth weight, birth order, maternal age at the 
time of delivery, maternal birthplace, and delivery method (vaginal or cesarean).  As a result, a 
total of 7 cases and 78 controls were excluded.  We further excluded individuals (100 cases and 
729 controls) with values that were outside of plausible ranges for birth weight (350g – 5,999g) 
and/or gestational age (20 – 44 weeks).  As cases and controls were individually matched, any 
case without matched control, or vice versa, was excluded.  This resulted in a final study 
population which consisted of 1,216 pediatric HL cases and 4,485 matched controls.     
 
Variables of Interest 
Data on birth weight, as well as various other infant, maternal, and paternal 
characteristics were obtained from birth records.  We considered the following variables as 
potential confounders of the relation between birth weight and risk of pediatric HL:  gestational 
age, birth order, plurality, maternal age at delivery, maternal birthplace, maternal education level, 
paternal age at delivery, paternal education level, delivery method, maternal history of diabetes, 
maternal history of pregnancy loss (defined as history of miscarriage and/or stillbirth), and 
proportion of the population living in poverty in the zip code of the mother’s residence at time of 
delivery (as a proxy for socioeconomic status).  Additional information about the diagnosis of 
pediatric HL, such as age at diagnosis and histological subtype, was obtained from the California 





Infant and parental characteristics were categorized and compared between cases and 
controls using Pearson’s Chi-square test.  To evaluate the association between birth weight and 
risk of pediatric HL, multivariable conditional logistic regression models (conditioned on 
matching factors of sex, race/ethnicity, and month/year of birth) were used to estimate odds 
ratios (ORs) and 95% confidence intervals (CIs).  We examined birth weight, the primary 
exposure of interest, as both a categorical and continuous variable.  For categorical analysis, 
birth weights were defined as low birth weight (<2,500g), normal birth weight (2,500g – 3,999g), 
and high birth weight (≥4,000g).  For the multivariable analysis, the initial model included 







higher), plurality (singleton versus multiple birth), maternal age the time of delivery (<20, 20-24, 
25-29, 30-34, and ≥35 years), maternal birthplace (foreign- versus US-born), maternal education 
level (12
th
 grade or less, more than 12
th
 grade, and unknown), paternal age at the time of delivery 
(<20, 20-24, 25-29, 30-34, ≥35 years, and unknown), paternal education level (12
th
 grade or less, 
more than 12
th
 grade, and unknown), delivery method (vaginal or cesarean), maternal history of 
diabetes, maternal history of pregnancy loss, and the proportion of the population living in 
poverty within the zip code of the mother’s residence at the time of delivery (<5%, 5-9%, 10-
19%, ≥20%, and unknown).  After a stepwise selection, the final model evaluating the 
association between birth weight and risk of overall pediatric HL adjusted for birth order, 
maternal age at the time of delivery, and paternal age at the time of delivery.   
We further evaluated the relationship between birth weight and risk of pediatric HL by 
age at diagnosis (0-10, 0-14, 11-14, and 15-19 years), histological subtype, and race/ethnicity.   
5 
 
Within each subgroup, covariates in the final models were also obtained using stepwise selection 
procedures.  
We also conducted a sensitivity analysis in which unconditional logistic regression 
models were performed that included the matching factors as well as all other covariates 
described above.  All significance tests were two-sided with an α-level of 0.05.  All analyses 
were conducted using SAS, version 9.4 (SAS Institute, Inc., Cary, North Carolina). 
 
Results 
Of the 1,216 pediatric HL cases included in the study, a majority (55.8%) were male, and 
53.4% were diagnosed at 15-19 years of age (Table 1, Figure 1).  Based on unadjusted 
associations, cases and controls were significantly different with respect to birth weight (p=0.01).  
Cases appeared to have a higher birth weight than controls, with 14.8% of cases having a high 
birth weight compared to 12.1% of controls, and 4.3% of cases presenting a low birth weight 
compared to 5.6% of controls.  Cases and controls were also significantly different with respect 
to maternal age at the time of delivery (p<0.01) and paternal age at the time of delivery (p<0.01).  
At the time of delivery, parents of cases were older than parents of controls.  Cases and controls 
also differed with respect to delivery method (p=0.04).  Cases were more likely to be delivered 
by cesarean section (24.9% for cases compared to 22.1% for controls).  The remaining 
characteristics were similar between cases and controls (Table 1).  
Based on the final multivariable conditional logistic regression model (Table 2), 
compared to normal birth weight, high birth weight was positively associated with risk of 
pediatric HL (OR=1.23, 95% CI: 1.02-1.48; p=0.03).  Low birth weight showed a nonsignificant 
protective effect against risk of pediatric HL (OR=0.79, 95% CI: 0.58-1.07; p=0.13).  When birth 
6 
 
weight was modelled continuously, a 1,000g increase in birth weight was associated with a 16% 
increase in risk of pediatric HL (95% CI: 1.03-1.30; p=0.01).  Compared with first born children, 
children who were third or higher in birth order had significantly reduced risk of pediatric HL 
(OR=0.80, 95% CI: 0.67-0.95; p=0.01).  There was also suggestion that younger parental age 
was associated with reduced risk of pediatric HL in the overall study population (Table 2). 
 In further analyses evaluating the relationship between birth weight and pediatric HL by 
age of diagnosis (Tables 2-3, Figure 2), significant positive associations for high birth weight and 
risk of HL were observed among those diagnosed at 0-10 years (OR=1.56, 95% CI: 1.04-2.34; 
p=0.03), or 15-19 years (OR=1.43, 95% CI: 1.11-1.83; p<0.01).  There was no significant 
association between birth weight and risk of HL diagnosed at the ages of 0-14 years or 11-14 
years.  Within the age group of 15-19 years, low birth weight was significantly associated with a 
44% decrease in odds of HL (OR=0.56, 95% CI: 0.36-0.89; p=0.01), an association which was 
absent in the overall study population (Tables 2-3). In addition, the association between birth 
order and risk of HL also varied by age of diagnosis, in that a significant association was 
observed among those diagnosed at 15-19 years (OR=0.66, 95% CI: 0.52-0.84; p<0.01), but not 
among those diagnosed at 0-14 years (Table 2). 
Additional stratified analyses by histological subtype and race/ethnicity revealed that 
high birth weight was significantly associated with increased disease risk among cases with the 
subtype of nodular sclerosis (OR=1.26, 95% CI: 1.02-1.57; p=0.03), but not among other 
subgroups (Table 3).  Results from the sensitivity analysis using unconditional logistic regression 






In this large population-based study, we found that high birth weight was associated with 
an increased risk of pediatric HL.  Additionally, birth order was associated with risk of pediatric 
HL, and having a birth order of third or higher (compared to being the first born child) conferred 
a significant protective effect.  However these effects were not consistent across subgroups 
defined by age of diagnosis, histological subtype, and race/ethnicity.   
For high birth weight and risk of pediatric HL, the magnitude of association was stronger 
in certain subgroups defined by age (0-10 years and 15-19 years), but it was absent in others (0-
14 years and 11-14 years).  Similarly, across subgroups, third or higher birth order (compared to 
first born) was only associated with decreased disease risk among cases diagnosed at 15-19 years 
of age.  It is not clear why these associations were not consistent across subgroups, but it is 
possible that HL diagnosed at different ages may have distinct etiology.  HL incidence varies by 
age, following a bimodal age distribution with peaks between 15-34 years and greater than 60 
years,
14




A majority of cases in our study population were classified as nodular sclerosis based on 
histology, and the relationship between birth weight and risk of pediatric HL in this subgroup 
mirrored the results from the overall population.  As the histological subtype of mixed cellularity 
is much rarer, we were unable to assess whether the apparent absence of association between 
birth weight and this subtype was due to small sample size and limited power, or any possible 
difference in etiology.    
Although high birth weight has been implicated as a risk factor for several other types of 
pediatric cancer, such as leukemia, neuroblastoma, brain tumors (astrocytoma and 
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medulloblastoma), and Wilms’ tumor,
16-20
 the role of birth weight in the etiology of pediatric HL 
is not as clear. The positive association between high birth weight and risk of HL had previously 
been reported to be similar in cases diagnosed at 0-14 years and 15-37 years.
13
  Milne et al. 
utilized proportion of optimal birth weight (POBW) as a metric for appropriateness of fetal 
growth
21
 and found that a higher POBW was associated with an increased risk of childhood HL 
(age 0-14 years) in boys.
22
  Aside from these studies, the majority of previously published 
studies that have evaluated birth weight and risk of HL in pediatric populations have reported 
null findings,
4-12
 and most of those studies included only cases diagnosed at the age of 0-14 
years.
4-6,8,10,11
  When we restricted our cases to those diagnosed at the age of 0-14 years, we also 
observed a similar null finding.  In future epidemiological research of pediatric HL, it is probably 
important to consider age of diagnosis as a potential marker for distinct underlying etiology. 
Our results pointed to a decreased risk of pediatric HL for those with a birth order of third 
or higher.  A study which evaluated HL risk in a young adult population (aged 15-39 years at the 
time of diagnosis) identified a protective effect for higher birth order in which those born fourth 
or later in their family had reduced risk of HL (relative to those born third or earlier).
23
  Another 
study reported significantly different risk patterns for birth order between childhood (<15 years) 
and young adult (≥15 years) populations, such that higher birth order appeared to decrease risk of 
HL in the young adult population and (non-significantly) increase risk of HL in children under 
15 years.
24
  These differing risk patterns for birth order and risk of HL between childhood and 
young adult populations are particularly noteworthy in the context our results.  Although higher 
birth order corresponded to decreased HL risk in our overall study population (0-19 years), 
subgroup analyses revealed that birth order was only a significant predictor in the aged 15-19 
years population.  As such, the effect of birth order on risk of HL may be modified by age at 
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diagnosis.  Alternatively, a higher incidence of HL in the age group of 15-19 years may simply 
offer an improved statistical power to detect an association, if one truly exists.   
 Our study has several important strengths.  Population-based record linkage in a state as 
populous as California gave rise to a large number of pediatric HL cases relative to earlier 
studies, and presented a significant advantage in terms of statistical power.  A record-based study 
without the need to trace or consent any subjects minimized concerns of selection bias.  
Additionally, data on exposure of interest, potential confounders, and disease outcome were 
obtained exclusively from preexisting records, which minimized any potential for recall bias.   
 In light of these noted advantages, there were also limitations to our study.  In particular, 
we were limited to data available in existing records, and therefore could not adjust for additional 
possible risk factors for pediatric HL such as maternal smoking during pregnancy
25
 and history 
of Epstein-Barr virus (EBV) infection or infectious mononucleosis.
26,27
  Nevertheless, a recent 
study conducted by the Children’s Oncology Group reported that fewer than 24% of childhood 
HL cases had EBV-positive tumor, and there did not appear to be systematic differences in risk 
factors by EBV status.
28
  In addition, we did adjust for a number of other potential confounder 
based on information contained in birth records, and we excluded individuals with missing or 
improbable values for important variables in order to ensure high data quality.  Finally, it is 
possible that some cases were not captured by the California Cancer Registry as a result of 
moving out of California or incomplete case ascertainment, and some control patients may have 
been misclassified.  However, under the extreme assumption that all controls were lost to follow-
up, based on the age-adjusted incidence rates of pediatric HL (age 0-19 years) for the United 
States over the study period,
2
 only fewer than two incident cases of HL would have arisen from 
10 
 
the 4,485 controls, had they been followed through their 20
th
 birthday.  As such, the potential for 
bias due to misclassification of the disease outcome was minimal.   
 In conclusion, this study provides evidence for a positive association between high birth 
weight and risk of pediatric HL.  The different findings by age of diagnosis with regard to both 
birth weight and birth order suggest that it may be important to stratify pediatric HL by age at 
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 Characteristics n (%) 
 
n (%) p-value* 
Total 1216   4485   
Sex 
     
0.84 
 









     
1.00 
 




















Other 18 (1.5) 
 
62 (1.4) 
 Year of birth 
     
0.72 
 















1993-2009 243 (20.0) 
 
921 (20.5) 
 Birth weight (in grams) 
     
0.01 
 










High (≥4000) 180 (14.8) 
 
542 (12.1) 
 Gestational age (in weeks) 
     
0.51 
 










42-44 131 (10.8) 
 
501 (11.2) 
 Birth order 

















3rd or higher 324 (26.6) 
 
1248 (27.8) 
 Plurality      0.17 
 
Singleton 1186 (97.5)  4402 (98.1) 
 
 
Multiple 30 (2.5)  83 (1.9) 
 Maternal age at delivery (in years) 
     
<.01 
 




















≥35 141 (11.6) 
 
451 (10.1) 
 Maternal education level 
     
0.81 
 
















Paternal age at delivery (in years) 
     
<.01 
 

























Unknown 47 (3.9) 
 
203 (4.5) 
 Paternal education level 
     
0.65 
 










Unknown 633 (52.1) 
 
2293 (51.1) 
 Maternal birthplace 
     
0.25 
 





Foreign 417 (34.3) 
 
1460 (32.6) 
 Delivery method 
     
0.04 
 





Cesarean 303 (24.9) 
 
991 (22.1) 
 Maternal diabetes 
     
0.61 
 





Yes 9 (0.7) 
 
40 (0.9) 
 History of pregnancy loss 
     
0.23 
 










Unknown 1 (0.1) 
 
13 (0.3) 
 % population living in poverty (by zip code) 
     
0.53 
 















≥20% 215 (17.7) 
 
832 (18.6) 
   Unknown 216 (17.8)   772 (17.2)   
*P-values were calculated using Pearson's Chi-square test 





Table 2: Factors associated with risk of pediatric Hodgkin lymphoma 
Characteristics OR* (95% CI)* p-value 
Overall; ages 0-19 years (1216 cases/4485 controls) 
 




Low (<2500) 0.79 (0.58, 1.07) 0.13 
 
 




High (≥4000) 1.23 (1.02, 1.48) 0.03 
 
 












 1.02 (0.87, 1.19) 0.79 
 
 
3rd or higher 0.80 (0.67, 0.95) 0.01 
 
Maternal age at delivery (in years) 
  
<20 0.66 (0.48, 0.89) <0.01 
 
 
20-24 0.73 (0.60, 0.88) <0.01 
 
 




30-34 1.03 (0.86, 1.24) 0.76 
 
 
≥35 0.94 (0.73, 1.21) 0.63 
 
Paternal age at delivery (in years) 
  
<20 0.99 (0.66, 1.51) 0.98 
 
 
20-24 0.76 (0.61, 0.95) 0.02 
 
 




30-34 0.94 (0.78, 1.14) 0.54 
 
 
≥35 1.22 (0.98, 1.52) 0.08 
 
 
Unknown 0.90 (0.63, 1.28) 0.56 
Ages 0-14 years (567 cases/2100 controls) 
 
Birth weight (in grams) 
  
Low (<2500) 1.10 (0.72, 1.70) 0.66 
 
 




High (≥4000) 1.07 (0.81, 1.42) 0.62 
 
 
Per 1,000g increase 1.01 (0.85, 1.20) 0.93 
 
Maternal age at delivery (in years) 
  
<20 0.81 (0.59, 1.13) 0.21 
 
 
20-24 0.74 (0.57, 0.96) 0.02 
 
 




30-34 1.02 (0.79, 1.32) 0.88 
 
 








Foreign 1.28 (1.01, 1.62) 0.04 
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Ages 15-19 years (649 cases/2385 controls) 
 
Birth weight (in grams) 
  
Low (<2500) 0.56 (0.36, 0.89) 0.01 
 
 




High (≥4000) 1.43 (1.11, 1.83) <0.01 
 
 












 0.96 (0.77, 1.19) 0.69 
 
 
3rd or higher 0.66 (0.52, 0.84) <0.01 
 
Maternal age at delivery (in years) 
  
<20 0.48 (0.30, 0.76) <0.01 
 
 
20-24 0.67 (0.51, 0.87) <0.01 
 
 




30-34 1.01 (0.78, 1.31) 0.93 
 
 
≥35 0.90 (0.63, 1.29) 0.57 
 
Maternal education level 
  




More than 12th grade 0.90 (0.67, 1.23) 0.51 
 
 
Unknown 1.23 (0.37, 4.06) 0.74 
 
Paternal age at delivery (in years) 
  
<20 0.99 (0.51, 1.93) 0.98 
 
 
20-24 0.69 (0.51, 0.95) 0.02 
 
 




30-34 0.93 (0.72, 1.20) 0.57 
 
 
≥35 1.37 (1.02, 1.84) 0.04 
 
 
Unknown 0.72 (0.41, 1.25) 0.24 
 
% population living in poverty (by zip code) 
  
<5% 1.30 (0.97, 1.75) 0.08 
 
 
5-9% 0.84 (0.64, 1.09) 0.18 
 
 




≥20% 1.01 (0.76, 1.35) 0.94 
 
  Unknown 0.82 (0.47, 1.44) 0.49 
*Odds ratios (OR) were derived from multivariable stepwise conditional logistic 















Table 3: Birth weight and risk of pediatric Hodgkin lymphoma by age of diagnosis, histological subtype, and 
race/ethnicity 
    Birth weight  (in grams) 
    Low (<2500) Normal (2500-3999) High (≥4000) 
Group Cases/controls OR (95% CI)* p-value   OR (95% CI)* p-value 
Overall (0-19 years)
a
 1216/4485 0.79 (0.58, 1.07) 0.13 1.00 (reference) 1.23 (1.02, 1.48) 0.03 
Age at Diagnosis 
     
  
   0-10 years
b
 241 /904  0.64 (0.28, 1.44) 0.28 1.00 (reference) 1.56 (1.04, 2.34) 0.03 
   0-14 years
c
 567 /2100  1.10 (0.72, 1.70) 0.66 1.00 (reference) 1.07 (0.81, 1.42) 0.62 
   11-14 years
d
 326 /1196  1.40 (0.83, 2.37) 0.21 1.00 (reference) 0.81 (0.55, 1.20) 0.30 
   15-19 years
e
 649 /2385  0.56 (0.36, 0.89) 0.01 1.00 (reference) 1.43 (1.11, 1.83) <0.01 
Histological Subtype 
     
  
   Nodular sclerosis
f
 883 /3259  0.73 (0.50, 1.06) 0.10 1.00 (reference) 1.26 (1.02, 1.57) 0.03 
   Mixed cellularity
g
 124 /464  0.88 (0.33, 2.36) 0.80 1.00 (reference) 0.85 (0.46, 1.58) 0.61 
Race/Ethnicity 
       
   Non-Hispanic white
h
 562 /2089  0.46 (0.24, 0.89) 0.02 1.00 (reference) 1.27 (0.98, 1.64) 0.07 
   Hispanic
i
 467 /1713  1.15 (0.72, 1.83) 0.56 1.00 (reference) 1.19 (0.87, 1.63) 0.27 
*Abbreviations:  CI, confidence interval; OR, odds ratio. 
a
Adjusted for birth order, maternal age at delivery, and paternal age at delivery. 
b
Adjusted for maternal education level.  
c
Adjusted for maternal age at delivery and maternal birthplace. 
d
Adjusted for maternal birthplace, and % population living in poverty (by zip code).  
e
Adjusted for birth order, maternal age at delivery, maternal education level, paternal age at delivery, and % population living in poverty    
  (by zip code).  
f
Adjusted for paternal age at delivery, delivery method, and % population living in poverty (by zip code).
   
 g
Unadjusted (no significant predictors remained after stepwise regression). 
 h
Adjusted for gestational age, maternal age at delivery, paternal age at delivery, maternal birthplace and % population living in poverty (by  
  zip code).  
i
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